SLC2A1 and breast cancer: Pinheiro et al. evaluated GLUT1 levels in 124 cases of breast cancer that were stratified by subtype, receptor status, and other molecular markers, and demonstrated that GLUT1 was associated with increased tumor size, higher tumor grade, higher rates of proliferation, and was predominately expressed in the basal subtype [17].